Packaged Foods
Compare Stocks
5 / 10Stock Comparison
FAMI vs AVO vs PRLB vs BRBS vs TSN
Revenue, margins, valuation, and 5-year total return — side by side.
Food Distribution
Manufacturing - Metal Fabrication
Banks - Regional
Agricultural Farm Products
FAMI vs AVO vs PRLB vs BRBS vs TSN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaged Foods | Food Distribution | Manufacturing - Metal Fabrication | Banks - Regional | Agricultural Farm Products |
| Market Cap | $12M | $942M | $1.62B | $320M | $24.18B |
| Revenue (TTM) | $130M | $1.34B | $546M | $151M | $55.71B |
| Net Income (TTM) | $-4M | $33M | $26M | $11M | $453M |
| Gross Margin | 5.2% | 12.0% | 44.9% | 63.5% | 6.6% |
| Operating Margin | 1.2% | 4.8% | 5.8% | 9.1% | 2.3% |
| Forward P/E | — | 20.2x | 37.5x | 31.8x | 17.5x |
| Total Debt | $15M | $201M | $5M | $179M | $8.83B |
| Cash & Equiv. | $487K | $65M | $111M | $116M | $1.23B |
FAMI vs AVO vs PRLB vs BRBS vs TSN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 20 | May 26 | Return |
|---|---|---|---|
| Farmmi, Inc. (FAMI) | 100 | 0.1 | -99.9% |
| Mission Produce, In… (AVO) | 100 | 100.8 | +0.8% |
| Proto Labs, Inc. (PRLB) | 100 | 57.6 | -42.4% |
| Blue Ridge Bankshar… (BRBS) | 100 | 38.6 | -61.4% |
| Tyson Foods, Inc. (TSN) | 100 | 118.7 | +18.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FAMI vs AVO vs PRLB vs BRBS vs TSN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, FAMI doesn't own a clear edge in any measured category.
AVO has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.
- Rev growth 12.7%, EPS growth 1.9%, 3Y rev CAGR 10.0%
- Lower volatility, beta 0.32, Low D/E 32.4%, current ratio 1.95x
- 12.7% revenue growth vs FAMI's -41.9%
- Beta 0.32 vs PRLB's 1.84
PRLB is the #2 pick in this set and the best alternative if momentum and efficiency is your priority.
- +76.0% vs FAMI's -28.8%
- 3.4% ROA vs FAMI's -1.6%, ROIC 3.4% vs 0.3%
BRBS ranks third and is worth considering specifically for defensive.
- Beta 0.54, yield 6.1%
- 7.1% margin vs FAMI's -2.9%
- 6.1% yield, vs TSN's 2.9%, (3 stocks pay no dividend)
TSN is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 13 yrs, beta 0.33, yield 2.9%
- 23.1% 10Y total return vs PRLB's 13.7%
- Lower P/E (17.5x vs 31.8x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.7% revenue growth vs FAMI's -41.9% | |
| Value | Lower P/E (17.5x vs 31.8x) | |
| Quality / Margins | 7.1% margin vs FAMI's -2.9% | |
| Stability / Safety | Beta 0.32 vs PRLB's 1.84 | |
| Dividends | 6.1% yield, vs TSN's 2.9%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +76.0% vs FAMI's -28.8% | |
| Efficiency (ROA) | 3.4% ROA vs FAMI's -1.6%, ROIC 3.4% vs 0.3% |
FAMI vs AVO vs PRLB vs BRBS vs TSN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FAMI vs AVO vs PRLB vs BRBS vs TSN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BRBS leads in 1 of 6 categories
FAMI leads 1 • PRLB leads 1 • AVO leads 0 • TSN leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BRBS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TSN is the larger business by revenue, generating $55.7B annually — 428.2x FAMI's $130M. BRBS is the more profitable business, keeping 7.1% of every revenue dollar as net income compared to FAMI's -2.9%. On growth, PRLB holds the edge at +10.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $130M | $1.3B | $546M | $151M | $55.7B |
| EBITDAEarnings before interest/tax | $2M | $91M | $57M | $15M | $2.7B |
| Net IncomeAfter-tax profit | -$4M | $33M | $26M | $11M | $453M |
| Free Cash FlowCash after capex | -$52M | $38M | $65M | $9M | $1.2B |
| Gross MarginGross profit ÷ Revenue | +5.2% | +12.0% | +44.9% | +63.5% | +6.6% |
| Operating MarginEBIT ÷ Revenue | +1.2% | +4.8% | +5.8% | +9.1% | +2.3% |
| Net MarginNet income ÷ Revenue | -2.9% | +2.5% | +4.7% | +7.1% | +0.8% |
| FCF MarginFCF ÷ Revenue | -39.8% | +2.9% | +12.0% | +2.5% | +2.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -55.7% | -16.6% | +10.4% | — | +4.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -181.3% | -118.2% | +120.0% | +2.6% | +36.1% |
Valuation Metrics
FAMI leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 25.1x trailing earnings, AVO trades at a 68% valuation discount to PRLB's 77.3x P/E. On an enterprise value basis, AVO's 10.2x EV/EBITDA is more attractive than BRBS's 25.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $12M | $942M | $1.6B | $320M | $24.2B |
| Enterprise ValueMkt cap + debt − cash | $27M | $1.1B | $1.5B | $383M | $31.8B |
| Trailing P/EPrice ÷ TTM EPS | -1.76x | 25.09x | 77.34x | 31.82x | 49.95x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.15x | 37.53x | — | 17.46x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.76x | — | — | — |
| EV / EBITDAEnterprise value multiple | 19.47x | 10.16x | 25.21x | 25.54x | 11.34x |
| Price / SalesMarket cap ÷ Revenue | 0.19x | 0.68x | 3.04x | 2.13x | 0.44x |
| Price / BookPrice ÷ Book value/share | 0.05x | 1.53x | 2.46x | 1.15x | 1.30x |
| Price / FCFMarket cap ÷ FCF | — | 25.33x | 27.14x | 85.53x | 20.55x |
Profitability & Efficiency
Evenly matched — AVO and PRLB each lead in 5 of 9 comparable metrics.
Profitability & Efficiency
AVO delivers a 5.5% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-2 for FAMI. PRLB carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRBS's 0.55x. On the Piotroski fundamental quality scale (0–9), AVO scores 6/9 vs FAMI's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.2% | +5.5% | +3.8% | +3.1% | +2.5% |
| ROA (TTM)Return on assets | -1.6% | +3.3% | +3.4% | +0.4% | +1.3% |
| ROICReturn on invested capital | +0.3% | +7.2% | +3.4% | +2.0% | +4.1% |
| ROCEReturn on capital employed | +0.5% | +8.6% | +3.8% | +0.5% | +4.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.09x | 0.32x | 0.01x | 0.55x | 0.48x |
| Net DebtTotal debt minus cash | $15M | $136M | -$106M | $63M | $7.6B |
| Cash & Equiv.Liquid assets | $486,522 | $65M | $111M | $116M | $1.2B |
| Total DebtShort + long-term debt | $15M | $201M | $5M | $179M | $8.8B |
| Interest CoverageEBIT ÷ Interest expense | 0.94x | 10.85x | — | 0.23x | 2.73x |
Total Returns (Dividends Reinvested)
PRLB leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TSN five years ago would be worth $9,840 today (with dividends reinvested), compared to $12 for FAMI. Over the past 12 months, PRLB leads with a +76.0% total return vs FAMI's -28.8%. The 3-year compound annual growth rate (CAGR) favors PRLB at 30.6% vs FAMI's -71.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -10.1% | +14.9% | +32.5% | -4.4% | +17.9% |
| 1-Year ReturnPast 12 months | -28.8% | +29.8% | +76.0% | +24.6% | +26.8% |
| 3-Year ReturnCumulative with dividends | -97.6% | +11.6% | +122.6% | -43.9% | +45.6% |
| 5-Year ReturnCumulative with dividends | -99.9% | -33.0% | -32.9% | -67.7% | -1.6% |
| 10-Year ReturnCumulative with dividends | -100.0% | -3.6% | +13.7% | -12.5% | +23.1% |
| CAGR (3Y)Annualised 3-year return | -71.1% | +3.7% | +30.6% | -17.5% | +13.3% |
Risk & Volatility
Evenly matched — AVO and TSN each lead in 1 of 2 comparable metrics.
Risk & Volatility
AVO is the less volatile stock with a 0.32 beta — it tends to amplify market swings less than PRLB's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TSN currently trades 97.8% from its 52-week high vs FAMI's 52.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.14x | 0.32x | 1.84x | 0.54x | 0.33x |
| 52-Week HighHighest price in past year | $2.22 | $15.53 | $70.00 | $4.79 | $69.48 |
| 52-Week LowLowest price in past year | $1.10 | $10.00 | $36.15 | $3.25 | $50.56 |
| % of 52W HighCurrent price vs 52-week peak | +52.3% | +85.6% | +97.2% | +73.1% | +97.8% |
| RSI (14)Momentum oscillator 0–100 | 44.7 | 47.3 | 69.4 | 35.1 | 64.5 |
| Avg Volume (50D)Average daily shares traded | 15K | 925K | 145K | 380K | 2.7M |
Analyst Outlook
Evenly matched — BRBS and TSN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AVO as "Buy", PRLB as "Hold", TSN as "Buy". Consensus price targets imply 42.9% upside for AVO (target: $19) vs -43.4% for PRLB (target: $39). For income investors, BRBS offers the higher dividend yield at 6.08% vs TSN's 2.95%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | — | Buy |
| Price TargetConsensus 12-month target | — | $19.00 | $38.50 | — | $70.25 |
| # AnalystsCovering analysts | — | 6 | 17 | — | 30 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +6.1% | +2.9% |
| Dividend StreakConsecutive years of raises | — | 3 | — | 0 | 13 |
| Dividend / ShareAnnual DPS | — | — | — | $0.21 | $2.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.6% | +2.7% | +3.0% | +0.8% |
BRBS leads in 1 of 6 categories (Income & Cash Flow). FAMI leads in 1 (Valuation Metrics). 3 tied.
FAMI vs AVO vs PRLB vs BRBS vs TSN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FAMI or AVO or PRLB or BRBS or TSN a better buy right now?
For growth investors, Mission Produce, Inc.
(AVO) is the stronger pick with 12. 7% revenue growth year-over-year, versus -41. 9% for Farmmi, Inc. (FAMI). Mission Produce, Inc. (AVO) offers the better valuation at 25. 1x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate Mission Produce, Inc. (AVO) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FAMI or AVO or PRLB or BRBS or TSN?
On trailing P/E, Mission Produce, Inc.
(AVO) is the cheapest at 25. 1x versus Proto Labs, Inc. at 77. 3x. On forward P/E, Tyson Foods, Inc. is actually cheaper at 17. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — FAMI or AVO or PRLB or BRBS or TSN?
Over the past 5 years, Tyson Foods, Inc.
(TSN) delivered a total return of -1. 6%, compared to -99. 9% for Farmmi, Inc. (FAMI). Over 10 years, the gap is even starker: TSN returned +23. 1% versus FAMI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FAMI or AVO or PRLB or BRBS or TSN?
By beta (market sensitivity over 5 years), Mission Produce, Inc.
(AVO) is the lower-risk stock at 0. 32β versus Proto Labs, Inc. 's 1. 84β — meaning PRLB is approximately 482% more volatile than AVO relative to the S&P 500. On balance sheet safety, Proto Labs, Inc. (PRLB) carries a lower debt/equity ratio of 1% versus 55% for Blue Ridge Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FAMI or AVO or PRLB or BRBS or TSN?
By revenue growth (latest reported year), Mission Produce, Inc.
(AVO) is pulling ahead at 12. 7% versus -41. 9% for Farmmi, Inc. (FAMI). On earnings-per-share growth, the picture is similar: Blue Ridge Bankshares, Inc. grew EPS 135. 5% year-over-year, compared to -118. 3% for Farmmi, Inc.. Over a 3-year CAGR, FAMI leads at 17. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FAMI or AVO or PRLB or BRBS or TSN?
Blue Ridge Bankshares, Inc.
(BRBS) is the more profitable company, earning 7. 1% net margin versus -7. 3% for Farmmi, Inc. — meaning it keeps 7. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BRBS leads at 9. 1% versus 1. 2% for FAMI. At the gross margin level — before operating expenses — BRBS leads at 63. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FAMI or AVO or PRLB or BRBS or TSN more undervalued right now?
On forward earnings alone, Tyson Foods, Inc.
(TSN) trades at 17. 5x forward P/E versus 37. 5x for Proto Labs, Inc. — 20. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVO: 42. 9% to $19. 00.
08Which pays a better dividend — FAMI or AVO or PRLB or BRBS or TSN?
In this comparison, BRBS (6.
1% yield), TSN (2. 9% yield) pay a dividend. FAMI, AVO, PRLB do not pay a meaningful dividend and should not be held primarily for income.
09Is FAMI or AVO or PRLB or BRBS or TSN better for a retirement portfolio?
For long-horizon retirement investors, Tyson Foods, Inc.
(TSN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 33), 2. 9% yield). Proto Labs, Inc. (PRLB) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TSN: +23. 1%, PRLB: +13. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FAMI and AVO and PRLB and BRBS and TSN?
These companies operate in different sectors (FAMI (Consumer Defensive) and AVO (Consumer Defensive) and PRLB (Industrials) and BRBS (Financial Services) and TSN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FAMI is a small-cap quality compounder stock; AVO is a small-cap quality compounder stock; PRLB is a small-cap quality compounder stock; BRBS is a small-cap income-oriented stock; TSN is a mid-cap quality compounder stock. BRBS, TSN pay a dividend while FAMI, AVO, PRLB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.